Alnylam Pharmaceuticals, Inc. (ETR:DUL)
Germany · Delayed Price · Currency is EUR 351.20
-7.10 (-1.98%)
Dec 10, 2025, 6:14 PM CET
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of €47.13 billion as of December 10, 2025. Its market cap has increased by 55.31% in one year.
Market Cap
47.13B
Enterprise Value
47.17B
Revenue
2.74B
Ranking
n/a
PE Ratio
1,269.35
Stock Price
€351.20
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 94.86M to 47.13B, an increase of 49,586.12%. That is a compound annual growth rate of 33.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 47.13B | 60.77% |
| Dec 31, 2024 | 29.32B | 34.90% |
| Dec 29, 2023 | 21.73B | -20.57% |
| Dec 30, 2022 | 27.36B | 53.40% |
| Dec 31, 2021 | 17.83B | 44.47% |
| Dec 31, 2020 | 12.34B | 7.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 51.78B |
| Siemens Healthineers AG | 48.33B |
| Bayer Aktiengesellschaft | 34.26B |
| Fresenius SE & Co. KGaA | 26.84B |
| Sartorius Aktiengesellschaft | 15.49B |
| Fresenius Medical Care AG | 11.32B |
| Carl Zeiss Meditec AG | 3.73B |
| Fielmann Group AG | 3.60B |